Roots Analysis has just released the 2nd edition of its publication "Prefilled Syringes Market, 2014 – 2024 (2nd edition)", acomprehensive study on the product pipeline, technological progress, latest developments and upcoming opportunity areas. The 230 page report offers deep insights based on market research and discussions with leading players in the industry.

Kamaruz Zaman, the principal analyst, said, “Owing to their numerous benefits over conventional delivery systems, these syringes have become indispensable in the medical field. This is evident from our research during which we identified a large number prefilled syringes being used to administer vaccines, anticoagulants, multiple sclerosis drugs, anti-arthritic drugs, anti-anaemic drugs and drugs from other classes.”

Zaman further stated, “Some of the key highlights from the study are:

The global market is likely to grow at a CAGR of 11.3% during 2013 – 2024; vaccines, diluent and flush syringes are likely to be some of the growth areas.
The emergence of biologics will be a major growth driver; growth in the long-term will be fuelled by pipeline drugs and the rising adoption in developing markets.
Developed markets together accounted for 80% share in 2013. With the increasing adoption in China and rest of the world, this domination is likely to decline to ~60% by 2024
The market is highly consolidated and is currently dominated by key global players such as Becton Dickinson, Gerresheimer, MGlas AG, SCHOTT and Nuova Ompi. New entrants, such as West Pharma and Unilife, are likely to foster innovation.
Many regional players, especially in China, Japan and other Asian economies, have also recently surfaced to exploit the opportunity offered by large home consumer markets.”

Leave a Reply

Your email address will not be published. Required fields are marked *

A new report published by Roots Analysis Private Ltd. forecasts the market for prefilled syringe systems to grow at a CAGR of 13.8% during the forecast period 2012-2018. According to the report titled ‘Prefilled Syringes World Market, 2012-2023, the prefilled syringes market is likely to witness sales of USD 6.9 BN in 2018, primarily driven by launch of new injectable drugs and vaccines, and increased preference for easy-to-use devices by end-users particularly in home-care situations. The grow till 2023 will continue to be robust.

Prefilled syringes are single-use devices that contain the premeasured dose of drug to be delivered. They offer better convenience, sterility and safety in comparison to conventional drug delivery systems like vials and ampoules. Prefilled syringes also considerably reduce the medication errors. Pharmaceutical companies are now packaging more of their injectable drugs in prefilled syringes, making it one of the fastest growing segments in injectable drug delivery systems market.

Leave a Reply

Your email address will not be published. Required fields are marked *